EMBARGOED FOR RELEASE:
Monday, Dec. 7, 2020
6:30 p.m. EST
CHICAGO - H. Steve White, R.Ph., Ph.D. was presented with the 2020 Extraordinary
Contributions to the Field of Epilepsy Award during the AES2020 event of the
American Epilepsy Society (AES). This award is designated for those who have made
extraordinary contributions across multiple fronts, including science, education,
leadership, and advocacy. The award is only presented in those years when the Board
of Directors determines there is an individual whose accomplishments embody the
spirit of the recognition.
Prof. White currently serves as Chair of the Department of Pharmacy at the University
of Washington School of Pharmacy. Dr. White earned his baccalaureate degree in
Pharmacy and a MS in Pharmacology at Idaho State University. He earned his PhD in
Pharmacology at the University of Utah where he served on the College of Pharmacy
faculty. Before joining the University of Washington Prof. White served as the
principal investigator and scientific director of the NIH-sponsored Anticonvulsant Drug
Development (ADD) Program.
Prof. White’s research is focused on understanding the factors that contribute to the
initiation, propagation, and amelioration of seizure activity and the development,
characterization and implementation of new seizure and epilepsy models for
evaluating anti-seizure drug efficacy. He and his collaborators have published over
200 original papers in this area. In addition to his academic service, he served as
Research Director of CURE Epilepsy, and continues to serve as a Research Advisor. He
has been a co-organizer of two NIH-sponsored workshops on models of refractory
epilepsy and epileptogenesis and currently serves on the organizing committee of the
biannual Eilat Conferences on Antiepileptic Drug Development.